Oaktree Acquisition Corp. III Life Sciences (OACC)

Market Cap	235.31M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	23.12M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,300
Open	10.20
Previous Close	10.18
Day's Range	10.18 - 10.20
52-Week Range	9.95 - 10.85
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About OACC

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Oct 24, 2024
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: OACC